| Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study CMM Prado, JR Lieffers, LJ McCargar, T Reiman, MB Sawyer, L Martin, ... The lancet oncology 9 (7), 629-635, 2008 | 1171 | 2008 |
| A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care M Mourtzakis, CMM Prado, JR Lieffers, T Reiman, LJ McCargar, ... Applied Physiology, Nutrition, and Metabolism 33 (5), 997-1006, 2008 | 723 | 2008 |
| Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment CMM Prado, VE Baracos, LJ McCargar, T Reiman, M Mourtzakis, ... Clinical Cancer Research 15 (8), 2920-2926, 2009 | 532 | 2009 |
| Muscle wasting is associated with mortality in patients with cirrhosis AJ Montano–Loza, J Meza–Junco, CMM Prado, JR Lieffers, VE Baracos, ... Clinical Gastroenterology and Hepatology 10 (2), 166-173. e1, 2012 | 395 | 2012 |
| Body composition as an independent determinant of 5-fluorouracil–based chemotherapy toxicity CMM Prado, VE Baracos, LJ McCargar, M Mourtzakis, KE Mulder, ... Clinical Cancer Research 13 (11), 3264-3268, 2007 | 324 | 2007 |
| Sarcopenic obesity: a critical appraisal of the current evidence CMM Prado, JCK Wells, SR Smith, BCM Stephan, M Siervo Clinical Nutrition 31 (5), 583-601, 2012 | 283 | 2012 |
| Lean Tissue Imaging A New Era for Nutritional Assessment and Intervention CMM Prado, SB Heymsfield Journal of Parenteral and Enteral Nutrition 38 (8), 940-953, 2014 | 188 | 2014 |
| A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands JR Lieffers, M Mourtzakis, KD Hall, LJ McCargar, CMM Prado, ... The American journal of clinical nutrition 89 (4), 1173-1179, 2009 | 183 | 2009 |
| The emerging role of computerized tomography in assessing cancer cachexia CMM Prado, LA Birdsell, VE Baracos Current opinion in supportive and palliative care 3 (4), 269-275, 2009 | 144 | 2009 |
| Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results L Thoresen, G Frykholm, S Lydersen, H Ulveland, V Baracos, CMM Prado, ... Clinical Nutrition 32 (1), 65-72, 2013 | 131 | 2013 |
| Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma J Meza-Junco, AJ Montano-Loza, VE Baracos, CMM Prado, VG Bain, ... Journal of clinical gastroenterology 47 (10), 861-870, 2013 | 127 | 2013 |
| Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation AJ Montano‐Loza, J Meza‐Junco, VE Baracos, CMM Prado, M Ma, ... Liver Transplantation 20 (6), 640-648, 2014 | 125 | 2014 |
| Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity KD Hall, T Bemis, R Brychta, KY Chen, A Courville, EJ Crayner, ... Cell metabolism 22 (3), 427-436, 2015 | 117 | 2015 |
| Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential? CM Prado, MB Sawyer, S Ghosh, JR Lieffers, N Esfandiari, S Antoun, ... The American journal of clinical nutrition 98 (4), 1012-1019, 2013 | 109 | 2013 |
| Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis AJ Montano‐Loza, P Angulo, J Meza‐Junco, CMM Prado, MB Sawyer, ... Journal of cachexia, sarcopenia and muscle 7 (2), 126-135, 2016 | 100 | 2016 |
| Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later AM Ryan, DG Power, L Daly, SJ Cushen, ĒN Bhuachalla, CM Prado Proceedings of the Nutrition Society 75 (2), 199-211, 2016 | 95 | 2016 |
| Osteosarcopenic obesity: the role of bone, muscle, and fat on health MJ Ormsbee, CM Prado, JZ Ilich, S Purcell, M Siervo, A Folsom, L Panton Journal of cachexia, sarcopenia and muscle 5 (3), 183-192, 2014 | 95 | 2014 |
| An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity CMM Prado, ISF Lima, VE Baracos, RR Bies, LJ McCargar, T Reiman, ... Cancer chemotherapy and pharmacology 67 (1), 93-101, 2011 | 89 | 2011 |
| Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity CMM Prado, S Antoun, MB Sawyer, VE Baracos Current Opinion in Clinical Nutrition & Metabolic Care 14 (3), 250-254, 2011 | 82 | 2011 |
| Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma CMM Prado, T Bekaii-Saab, LA Doyle, S Shrestha, S Ghosh, VE Baracos, ... British journal of cancer 106 (10), 1583, 2012 | 77 | 2012 |